首页> 外文期刊>Evidence-based complementary and alternative medicine: eCAM >Clinical Effect of Shenfu Injection in Patients with Septic Shock: A Meta-Analysis and Systematic Review
【24h】

Clinical Effect of Shenfu Injection in Patients with Septic Shock: A Meta-Analysis and Systematic Review

机译:Shenfu注射患者渗透休克患者的临床疗效:META分析和系统评论

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Purpose. To conduct a meta-analysis evaluating the efficacy of Shenfu injection for treating patients with septic shock when compared with conventional therapy. Methods. Eight databases including Pubmed, EMBASE, Cochrane Library, ISIWeb of Science, CNKI, Wanfang, VIP, and CBM were searched up to October 2014. Randomized controlled trials assessing the efficacy of Shenfu injection were identified. Mean arterial pressure, heart rate, lactate, and mortality were included as outcome measurements. Results. We analyzed data from 12 randomized controlled trials involving 904 participants. Compared with conventional therapy, Shenfu injection could further increase the mean arterial pressure at 1 hour (SMD 0.38; 95% CI, 0.01-0.74) and 6 hours (SMD 0.82; 95% CI, 0.03-1.61). Shenfu injection could further normalize heart rate at 6 hours (SMD -0.90; 95% CI, -1.47-0.33) and clear serum lactate at 6 hours (SMD -0.51; 95% CI, -0.70-0.32) and 24 hours (SMD, 0.52; 95% CI, -0.77-0.26). As the endpoint of mortality was not unified, it was not meta-analyzed. Conclusions. Based on the findings in present review, Shenfu injection is more effective than conventional therapy in increasing mean arterial pressure, normalizing heart rate, clearing serum lactate, and reducing mortality. These results should be confirmed in higher level clinical trials in the future.
机译:目的。与常规治疗相比,进行荟萃分析评估Shenfu注射液治疗脓毒症休克患者的疗效。方法。八个数据库包括PubMed,Embase,Cochrane图书馆,ISIWEB,CNKI,WANFANG,VIP和CBM,达到2014年10月。鉴定了评估沉府注射效果的疗效的随机对照试验。包括均结果测量的平均动脉压,心率,乳酸和死亡率。结果。我们分析了来自12名随机对照试验的数据,涉及904名参与者。与常规治疗相比,沉府注射液在1小时(SMD 0.38; 95%CI,0.01-0.74)和6小时(SMD 0.82; 95%CI,0.03-1.61)中进一步增加平均动脉压。 Shenfu注射可以在6小时(SMD -0.90; 95%CI,-1.47-0.33)下进一步将心率正常化,并在6小时(SMD -0.51; 95%CI,-0.0.0.32)和24小时(SMD)和澄清血清乳酸,0.52; 95%CI,-0.77-0.26)。随着死亡率的终点未统一,它没有荟萃分析。结论。基于本综述中的研究结果,Shenfu注射比常规治疗更有效,在增加平均动脉压,正常化心率,清除血清乳酸和降低死亡率。这些结果应在未来在更高水平的临床试验中确认。

著录项

  • 来源
  • 作者单位

    Beijing Union Med Coll Hosp Emergency Dept Beijing 100730 Peoples R China;

    Huazhong Univ Sci &

    Technol Tongji Hosp Dept Orthoped Tongji Med Coll Wuhan 430030 Peoples R;

    Beijing Union Med Coll Hosp Emergency Dept Beijing 100730 Peoples R China;

    Chinese Acad Med Sci Dept Epidemiol &

    Biostat Inst Basic Med Sci Sch Basic Med Peking Union Med;

    Chinese Acad Med Sci Dept Epidemiol &

    Biostat Inst Basic Med Sci Sch Basic Med Peking Union Med;

    Beijing Union Med Coll Hosp Emergency Dept Beijing 100730 Peoples R China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 临床医学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号